US Patent

US10646485 — Process of making stable abuse-deterrent oral formulations

Method of Use · Assigned to Collegium Pharmaceutical Inc · Expires 2036-09-02 · 10y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a process for making stable oral formulations that reduce the potential for improper administration of certain drugs, such as OxyContin.

USPTO Abstract

The present disclosure relates to cured pharmaceutical compositions designed to reduce the potential for improper administration of drugs that are subject to abuse, the process of curing such composition in order to improve the dissolution stability, method of using the same for treatment of pain.

Drugs covered by this patent

OxyContin (oxycodone) · Purdue Pharma

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1556`	—	OxyContin
`U-1556`	—	OxyContin
`U-1556`	—	OxyContin
`U-1556`	—	OxyContin
`U-1556`	—	OxyContin

Patent Metadata

Patent number: US10646485
Jurisdiction: US
Classification: Method of Use
Expires: 2036-09-02
Drug substance claim: No
Drug product claim: Yes
Assignee: Collegium Pharmaceutical Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.